Log in

Relevant bibliographies by topics / Papillomavirus diseases

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Papillomavirus diseases'

Author: Grafiati

Published: 4 June 2021

Last updated: 28 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Papillomavirus diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Papillomavirus diseases"

1

White, Elizabeth A. "Manipulation of Epithelial Differentiation by HPV Oncoproteins." Viruses 11, no. 4 (April 22, 2019): 369. http://dx.doi.org/10.3390/v11040369.

Full text

Abstract:

Papillomaviruses replicate and cause disease in stratified squamous epithelia. Epithelial differentiation is essential for the progression of papillomavirus replication, but differentiation is also impaired by papillomavirus-encoded proteins. The papillomavirus E6 and E7 oncoproteins partially inhibit and/or delay epithelial differentiation and some of the mechanisms by which they do so are beginning to be defined. This review will outline the key features of the relationship between HPV infection and differentiation and will summarize the data indicating that papillomaviruses alter epithelial differentiation. It will describe what is known so far and will highlight open questions about the differentiation-inhibitory mechanisms employed by the papillomaviruses.

APA, Harvard, Vancouver, ISO, and other styles

2

Torres, Sheila M. F., and Sandra N. Koch. "Papillomavirus-Associated Diseases." Veterinary Clinics of North America: Equine Practice 29, no. 3 (December 2013): 643–55. http://dx.doi.org/10.1016/j.cveq.2013.08.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Carrai, Maura, Kate Van Brussel, Mang Shi, Ci-Xiu Li, Wei-Shan Chang, John S. Munday, Katja Voss, et al. "Identification of a Novel Papillomavirus Associated with Squamous Cell Carcinoma in a Domestic Cat." Viruses 12, no. 1 (January 20, 2020): 124. http://dx.doi.org/10.3390/v12010124.

Full text

Abstract:

Papillomaviruses infect the skin and mucosal surfaces of diverse animal hosts with consequences ranging from asymptomatic colonization to highly malignant epithelial cancers. Increasing evidence suggests a role for papillomaviruses in the most common cutaneous malignancy of domestic cats, squamous cell carcinoma (SCC). Using total DNA sequencing we identified a novel feline papillomavirus in a nasal biopsy taken from a cat presenting with both nasal cavity lymphoma and recurrent squamous cell carcinoma affecting the nasal planum. We designate this novel virus as Felis catus papillomavirus 6 (FcaPV6). The complete FcaPV6 7453 bp genome was similar to those of other feline papillomaviruses and phylogenetic analysis revealed that it was most closely related to FcaPV3, although was distinct enough to represent a new viral type. Classification of FcaPV6 in a new genus alongside FcaPVs 3, 4 and 5 is supported. Archived excisional biopsy of the SCC, taken 20 months prior to presentation, was intensely positive on p16 immunostaining. FcaPV6, amplified using virus-specific, but not consensus, PCR, was the only papillomavirus detected in DNA extracted from the SCC. Conversely, renal lymphoma, sampled at necropsy two months after presentation, tested negative on FcaPV6-specific PCR. In sum, using metagenomics we demonstrate the presence of a novel feline papillomavirus in association with cutaneous squamous cell carcinoma.

APA, Harvard, Vancouver, ISO, and other styles

4

Knight, C. G., J. S. Munday, J. Peters, and M. Dunowska. "Equine Penile Squamous Cell Carcinomas Are Associated With the Presence of Equine Papillomavirus Type 2 DNA Sequences." Veterinary Pathology 48, no. 6 (January 31, 2011): 1190–94. http://dx.doi.org/10.1177/0300985810396516.

Full text

Abstract:

Forty cases of equine penile disease were screened with polymerase chain reaction for the presence of papillomaviral DNA. Cases consisted of 20 squamous cell carcinomas (average age of horse, 23.9 years) and 20 non–squamous cell carcinoma diseases (average age of horse, 13.3 years). All horses but one originated from the Northeastern United States. Breeds were not recorded. As based on MY09/MY11 consensus primers, DNA sequences from equine papillomavirus type 2 were amplified from 9 of 20 horses (45%) with penile squamous cell carcinoma and only 1 of 20 horses (5%) with non–squamous cell carcinoma penile disease. Equine papillomavirus type 2 DNA was the only papillomaviral DNA amplified from any of the 40 horses. Tissues from the 10 horses in which papillomaviral DNA was detected by polymerase chain reaction were also screened with in situ hybridization and immunohistochemistry. The presence of papillomavirus was demonstrated in a subset of these by in situ hybridization (6 of 10) and immunohistochemistry (1 of 10). This report describes a possible association between equine penile squamous cell carcinomas and equine papillomavirus type 2. This study is also the first report of equine papillomavirus type 2 infection in North American horses.

APA, Harvard, Vancouver, ISO, and other styles

5

Grce, Magdalena, and Marinka Mravak-Stipetić. "Human papillomavirus–associated diseases." Clinics in Dermatology 32, no. 2 (March 2014): 253–58. http://dx.doi.org/10.1016/j.clindermatol.2013.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Orth, G. "Papillomavirus." Médecine et Maladies Infectieuses 17, no. 11 (November 1987): 617. http://dx.doi.org/10.1016/s0399-077x(87)80113-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Suzuki, Mikio, Masahiro Hasegawa, Zeyi Deng, Hiroyuki Maeda, Asanori Kiyuna, and Takayuki Uehara. "Human Papillomavirus in Sinonasal Diseases." Otolaryngology–Head and Neck Surgery 147, no. 2_suppl (August 2012): P249. http://dx.doi.org/10.1177/0194599812451426a395.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Arron, Sarah Tuttleton, Peter Skewes-Cox, Phong H. Do, Eric Dybbro, Maria Da Costa, Joel M. Palefsky, and Joseph L. DeRisi. "Validation of a Diagnostic Microarray for Human Papillomavirus: Coverage of 102 Genotypes." Journal of Nucleic Acids 2011 (2011): 1–6. http://dx.doi.org/10.4061/2011/756905.

Full text

Abstract:

Papillomaviruses have been implicated in a variety of human diseases ranging from common warts to invasive carcinoma of the anogenital mucosa. Existing assays for genotyping human papillomavirus are restricted to a small number of types. Here, we present a comprehensive, accurate microarray strategy for detection and genotyping of 102 human papillomavirus types and validate its use in a panel of 91 anal swabs. This array has equal performance to traditional dot blot analysis with the benefits of added genotype coverage and the ability to calibrate readout over a range of sensitivity or specificity values.

APA, Harvard, Vancouver, ISO, and other styles

9

Hartmann, Samantha R., Daniel J. Goetschius, Jiafen Hu, Joshua J. Graff, Carol M. Bator, Neil D. Christensen, and Susan L. Hafenstein. "Cryo EM Analysis Reveals Inherent Flexibility of Authentic Murine Papillomavirus Capsids." Viruses 13, no. 10 (October 7, 2021): 2023. http://dx.doi.org/10.3390/v13102023.

Full text

Abstract:

Human papillomavirus (HPV) is a significant health burden and leading cause of virus-induced cancers. However, studies have been hampered due to restricted tropism that makes production and purification of high titer virus problematic. This issue has been overcome by developing alternative HPV production methods such as virus-like particles (VLPs), which are devoid of a native viral genome. Structural studies have been limited in resolution due to the heterogeneity, fragility, and stability of the VLP capsids. The mouse papillomavirus (MmuPV1) presented here has provided the opportunity to study a native papillomavirus in the context of a common laboratory animal. Using cryo EM to solve the structure of MmuPV1, we achieved 3.3 Å resolution with a local symmetry refinement method that defined smaller, symmetry related subparticles. The resulting high-resolution structure allowed us to build the MmuPV1 asymmetric unit for the first time and identify putative L2 density. We also used our program ISECC to quantify capsid flexibility, which revealed that capsomers move as rigid bodies connected by flexible linkers. The MmuPV1 flexibility was comparable to that of a HPV VLP previously characterized. The resulting MmuPV1 structure is a promising step forward in the study of papillomavirus and will provide a framework for continuing biochemical, genetic, and biophysical research for papillomaviruses.

APA, Harvard, Vancouver, ISO, and other styles

10

Zarochentseva, N. V., V. I. Krasnopolskiy, О. А. Misyukevich, I. V. Barinova, М. V. Mgeliashvili, and О. V. Rovinskaya. "Rare forms of vaginal diseases in women after panhysterectomy." Voprosy ginekologii, akušerstva i perinatologii 19, no. 5 (2020): 150–55. http://dx.doi.org/10.20953/1726-1678-2020-5-150-155.

Full text

Abstract:

The article presents clinical observations of the development of precancerous conditions of the vaginal vault, and also squamous cell cancer in women after panhysterectomy. The examination included: comprehensive vaginoscopy, cytological examination of vaginal wall smears, human papillomavirus test, histological examination of bioplates. Conclusion. Panhysterectomy does not guarantee the absence of precancerous lesions of the vagina or vaginal cancer. Therefore, routine screening (cytology, testing for high-risk human papillomavirus, vaginoscopy) should be continued in women after panhysterectomy with a history of cervical intraepithelial neoplasias for at least 20 years, even in women older than 65 years. Key words: vaginal intraepithelial neoplasia, human papillomavirus, panhysterectomy, papillomavirus infection, cervical cancer, photodynamic therapy

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Papillomavirus diseases"

1

Brestovac, Brian. "Human papillomavirus and cervical cancer in Western Australia." University of Western Australia. School of Biomedical and Chemical Sciences, 2005. http://theses.library.uwa.edu.au/adt-WU2006.0037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Liu, Xiao Song. "Mucosal immune responses to chimeric papillomavirus like particles in mice /." [St. Lucia, Qld.], 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16988.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kan, Chin-Yi. "Human Papillomavirus in human breast cancer and cellular immortalisation." Sydney : University of New South Wales. Biotechnology and Biomolecular Sciences, 2007. http://www.library.unsw.edu.au/~thesis/adt-NUN/public/adt-NUN20071004.080541/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dareng, Eileen Onyeche. "Human papillomavirus infections and human papillomavirus associated diseases in Nigeria : distribution, determinants and control." Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/284551.

Full text

Abstract:

Background: Persistent infection with high risk HPV is a necessary but insufficient cause of cervical cancer. Behavioural, viral and host factors modulate the risk of HPV persistence. In this thesis, I explore the role of the vaginal microbiota, a host factor and the presence of multiple HPV infections, a viral factor in HPV persistence. Considering the limited data on the epidemiology of HPV related diseases in low and middle-countries (LMIC), and the limited success of cervical cancer screening strategies in many LMIC, I provide data on the distribution of HPV related diseases in Nigeria and evaluate the acceptability of innovative strategies to increase cervical cancer screening uptake. Methods/Results: To achieve my aims, I implemented a longitudinal cohort study of 1,020 women in Nigeria. I begin my results chapters with two methodological papers. Attrition is an important consideration for every longitudinal cohort, particularly in LMIC, therefore, I present my findings on attrition, determinants of attrition and practical strategies to ensure low attrition in studies conducted in LMIC. Considering that sexual behaviour is an important potential confounder in all HPV studies, and the reliability of self-reported history is often questioned, I present findings on the test-retest reliability of self-reported sexual behaviour history collected in my study. Having found that attrition levels were low and that self-reported sexual behaviour history was generally reliable within my cohort, I present my findings on the association between the vaginal microbiota and persistent hrHPV; and the role of multiple HPV infections in viral persistence. I found that the vaginal microbiota was associated with persistent hrHPV in HIV negative women, but not in HIV positive women; and that multiple HPV infections did not increase the risk of viral persistence when compared to single HPV infections. Next, I present my findings on the prevalence and incidence of anogenital warts in Nigeria, with additional reports on the prevalence of cervical cancer and other HPV associated cancers using data from two population based cancer registries. Finally, I present my findings on the acceptability of innovative strategies to improve cervical cancer screening uptake in Nigeria. I found that Nigerian women had a favorable attitude to the use of HPV DNA based screening as part of routine antenatal care, however attitudes towards the use of self-sampling techniques for HPV based cervical cancer screening varied by religious affiliations. Conclusion: In my thesis, I was able to systematically investigate the epidemiology of HPV infections in a LMIC. I considered the distribution of HPV related diseases, host and viral determinants of HPV persistence and investigated control strategies to reduce the burden of cervical cancer in a LMIC. My results provide useful data for surveillance, monitoring and evaluation of control programs on HPV and cervical cancer in Nigeria and may be useful to cervical cancer control programs in other LMIC.

APA, Harvard, Vancouver, ISO, and other styles

5

Tse, Cheuk-ting. "The applicability of human papillomavirus immunization program for women in Hong Kong." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B42997872.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jarrell, Jennifer C. "Human papillomavirus vaccine policy in the United States." unrestricted, 2007. http://etd.gsu.edu/theses/available/etd-12052007-202826/.

Full text

Abstract:

Thesis (M.P.H.)--Georgia State University, 2007.
Title from file title page. Russ Toal, committee chair; Michael Eriksen, Cristen J. Suhr, committee members. Electronic text (76 p. : ill., col. map) : digital, PDF file. Description based on contents viewed Feb. 25, 2008. Includes bibliographical references (p. 66-72).

APA, Harvard, Vancouver, ISO, and other styles

7

Cheung, Ying Kit. "Study of the immunity of a human papillomavirus vaccine candidate /." View Abstract or Full-Text, 2003. http://library.ust.hk/cgi/db/thesis.pl?BIOL%202003%20CHEUNG.

Full text

Abstract:

Thesis (M. Phil.)--Hong Kong University of Science and Technology, 2003.
Includes bibliographical references (leaves 112-129). Also available in electronic version. Access restricted to campus users.

APA, Harvard, Vancouver, ISO, and other styles

8

Kay, Patti Sheryl. "Typing of human papillomavirus in Western Cape women with cervical intraepithelial neoplasia." Thesis, Cape Technikon, 2002. http://hdl.handle.net/20.500.11838/1471.

Full text

Abstract:

Thesis (MTech (Biomedical Technology))--Cape Technikon, Cape Town, 2002
Infection \\'ith specific high risk human papilloma"iruses (HPV) has been shown to play a causal role in the development of ceJVical intraepithelial neoplasia (CIN) and cenical cancer in women. The development of a prophylactic vaccine to immull.ize women against HPV infection would play a \'ita! role in protecting women against HPV infection and ultimately ceMcal cancer. Despite cancer of the cer\'ix being the second most common cancer in South African women, a literature search reveals that few studies have been performed in South Africa on the types of HPV prevalent in women with CIN or cancer ofthe ceMx. HPVs that infect the anogenital tract have also been shown to infect the oral ca\'ity. However, the HPV prevalence rates vary greatly between studies and the significance of the presence ofHPV in the oral ca\'ity is still not understood. The primary objectives of this study were to establish the HPV prevalence rate infecting women with CIN lesions using a sensitive nested polymerase chain reaction (PCR) and to develop a novel restriction fragment length polymorphism (RFLP) method to type the high risk mucosal HPVs detected in these women. The secondary objective of this study was to establish the prevalence rate and HPV types infecting the oral mucosa of women with CIN lesions and to compare these HPV types with those detected in the ceMx. Cemcal punch biopsies were taken from 163 women with CIN lesions and buccal cells were collected from 33 of these participants. DNAwas extracted from the biopsies and buccal samples and PCR using CCRS primers performed to ensure sample adequacy. Nested PCR usmg consensus degenerate primers for HPV was performed on all samples sho\\'wg sufficient amplifiable DNA A novel restriction fragment length pol)morphism (RFLP) method was developed to identify the 10 high risk mucosal HPVs considered human carcinogens of group 1 by the International Agency for Research on Cancer (lARC) as well as HPV 11 which is commonly found in the oral cavity.

APA, Harvard, Vancouver, ISO, and other styles

9

Gu, Zhengming. "Studies on molecular mechanisms of transformation by human papillomavirus : the role of E6 and E5 oncogenes." Thesis, McGill University, 1996. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=40133.

Full text

Abstract:

The ability of the HPV-18 E6 gene to impair p53-mediated transcriptional activity induced by DNA damaging agents was investigated. It is demonstrated that E6 can abolish DNA damage induced p53-mediated transcription and that a region from amino acid residue 113 to 117 of HPV-18 E6 protein was necessary for E6 to direct the degradation of p53. The biological importance of the E6/p53 interaction was then directly examined in HPV-16 containing cervical carcinoma derived cells by introducing the monomeric p53 mutant which is resistant to E6 mediated degradation. The two major observations made from this study were: (i) loss of p53 activity plays an important role in maintaining the malignant phenotype of these cells with respect to cell proliferation; (ii) the monomeric p53 mutant without its C-terminal regulatory region was biologically functional with respect to impairing cell proliferation in HPV-16 containing cervical carcinoma derived cells. Finally, it was revealed that the cellular MAP kinase signal transduction pathway was more active in cells expressing the HPV-16 E5 gene than in control cells or cells expressing E6 and E7. These observations help to define the mechanisms by which HPV oncogenes contribute to the development and maintenance of the neoplastic phenotype.

APA, Harvard, Vancouver, ISO, and other styles

10

Tse, Cheuk-ting, and 謝綽婷. "The applicability of human papillomavirus immunization program for women in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B42997872.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Papillomavirus diseases"

1

J, Syrjänen Kari, Gissmann L. 1949-, and Koss Leopold G, eds. Papillomaviruses and human disease. Berlin: Springer-Verlag, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Charles, Lacey, and Leeds Medical Information, eds. Papillomavirus reviews: Current research on papillomaviruses. Leeds: Leeds Medical Information, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

M, Steinberg Bettie, Brandsma Janet L, and Taichman Lorne B, eds. Papillomaviruses. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Guilfoile, Patrick. Human papillomavirus. Edited by Babcock Hilary. New York: Chelsea House, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Klooster, T. M. van 't. Adverse events following vaccination against human papillomavirus: Results of the 2010 campaign in the Netherlands. Bilthoven: National Institute for Public Health and the Environment, Ministry of Health, Welfare and Sport, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

David, Evered, and Clark Sarah, eds. Papillomaviruses. Chichester: n Wiley, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Syrjänen, Kari J. Human papillomavirus (HPV) involvement in esophageal carcinogenesis. New York: Nova Biomedical Books, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

The HPV vaccine controversy: Sex, cancer, god and politics : a guide for parents, women, men and teenagers. Westport, Conn: Praeger, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Renzo, Barrasso, and Gross G, eds. Human papilloma virus infection: A clinical atlas. Berlin: Ullstein Mosby, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Dizon, Don S. Dx/Rx: Human papilloma virus. Sudbury, MA: Jones & Bartlett Learning, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Papillomavirus diseases"

1

Garland, Suzanne M. "Human Papillomavirus." In Sexually Transmitted Diseases, 85–95. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118314937.ch10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Domachowske, Joseph, and Manika Suryadevara. "Human Papillomavirus." In Clinical Infectious Diseases Study Guide, 143–48. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-50873-9_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Suryadevara, Manika. "Human Papillomavirus Infection." In Introduction to Clinical Infectious Diseases, 181–90. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-91080-2_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Goldman, Linda. "Human Papillomavirus and Genital Warts." In Sexually Transmitted Diseases, 21–46. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-040-9_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Goldman, Linda Caryn, and Amy Lynn Clouse. "Human Papillomavirus and Genital Warts." In Sexually Transmitted Diseases, 1–17. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-499-9_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Passos, Mauro Romero Leal. "Infection with Human Papillomavirus (HPV)." In Atlas of Sexually Transmitted Diseases, 239–319. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57470-7_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Erdélyi, Károly, and Kevin Eatwell. "Papillomavirus and Polyomavirus Infections." In Infectious Diseases of Wild Mammals and Birds in Europe, 225–33. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118342442.ch16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jin, Xin, and Xin Zeng. "Human Papillomavirus Infections of Oral Mucosa." In Case Based Oral Mucosal Diseases, 161–67. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-0286-2_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Stier, Elizabeth A. "Cidofovir Against Human Papillomavirus-Associated Diseases." In Molecular Basis for Therapy of AIDS-Defining Cancers, 235–45. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-1513-9_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Gordon, Sara C., Mahesh C. Patel, Robert J. Cabay, and Hervé Y. Sroussi. "Benign Diseases Associated with Human Papillomavirus Infection." In HPV and Cancer, 131–62. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5437-9_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Papillomavirus diseases"

1

Tareq HAMMOODI, Zeyad. "CORONA EPIDEMIC (COVD 19) BETWEEN SHARIA AND MEDICINE." In International Research Congress of Contemporary Studies in Social Sciences (Rimar Congress 2). Rimar Academy, 2021. http://dx.doi.org/10.47832/rimarcongress2-7.

Full text

Abstract:

The Corona epidemic is a wide group of viruses that include viruses that can cause a group of illnesses in humans, ranging from the common cold to severe acute respiratory syndrome, as there is no definitive and specific treatment for the epidemic. The medicines used are helpful and supportive, and they mostly aim to reduce the patient’s temperature with the use of pulmonary resuscitation devices, as the body’s resistance depends on autoimmunity, as it is the main factor in preventing this epidemic, and here we must know the role of medical and forensic scholars in preventing and treating With what appears from this epidemic and other epidemics, we do not know when and how they will appear to the world. The emergence of this disease is an extension of several diseases before it and the so-called (contemporary diseases), which are contagious communicable diseases, including bird flonza disease, swine flonza, sass and AIDS, mad cow disease, Ebola, human papillomavirus, herpes simplex virus, yellow fever, and many others These diseases are epidemic.

APA, Harvard, Vancouver, ISO, and other styles

2

Zhao, J., and Z. Zhang. "AB0996 HUMAN PAPILLOMAVIRUS VACCINATION AWARENESS IN CHINESE AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES: A LARGE REAL-WORLD SURVEY." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.1751.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pereira, Igor Muzetti, and Vinícius Victor Lelis. "Developing a open-source serious game for control and education on HPV and Cervical Cancer." In Congresso Latino-Americano de Software Livre e Tecnologias Abertas. Sociedade Brasileira de Computação - SBC, 2019. http://dx.doi.org/10.5753/latinoware.2019.10344.

Full text

Abstract:

HPV - short for human papillomavirus - is a virus capable of infecting the mucous membranes and skin, being the most prevalent involved on Sexually Transmitted Diseases and the main cause of Cervical Cancer. However, reaching out to and inviting all eligible people for cervical cancer screening and vaccination against HPV is a difficult task. A possible solution is the use of social inducement and gamification through modern means of communication, which may encourage the attendance of unscreened or unvaccinated people on related programs. Therefore, this paper presents the development of a serious game for the Android platform designed for children and preteens with the purpose of foresting HPV and Cervical Cancer awareness, informationseeking, and communication, thus possibly increasing the number of vaccinated and screened people.

APA, Harvard, Vancouver, ISO, and other styles

4

Torrado García, LM, B. Rincón-Orozco, R. Martínez-Vega, and A. Olmo. "237 Association between high risk human papillomavirus infection and sexual transmission diseases in women of the metropolitan area of bucaramanga." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Muhammad Afzal, Afifa. "The Moderating Effect of Beliefs on HPV Awareness and HPV Vaccination Acceptance among Female Patients in Islamabad City." In 2nd International Conference on Public Health and Well-being. iConferences (Pvt) Ltd, 2021. http://dx.doi.org/10.32789/publichealth.2021.1001.

Full text

Abstract:

This research aimed to study the effect of awareness on the acceptability of human papillomavirus vaccination with belief acting as a moderator between the two variables. Quantitative research was conducted in a hospital with a specific focus on gynecological operations and family planning. The method of data collection comprised of a questionnaire, which was filled out by 50 women from various religious and cultural backgrounds. SPSS was used to conduct statistical analysis. The univariate, bivariate, and multivariate analyses indicated that the results were not conclusive with the hypothesis. The participants had no pre-existing information regarding vaccinations and the knowledge of the diseases being studied as opposed to the hypothesis. This research brings focus towards a deeply neglected area of reproductive healthcare in Pakistan. This includes a lack of awareness amongst the population regarding HPV. Lack of concrete and accurate knowledge directly affects the amount of awareness present in Pakistan regarding HPV, which is close to zero, as indicated by this study. This absence of awareness means that we, as healthcare practitioners, cannot research the current topic and expect it to produce any conclusive results.

APA, Harvard, Vancouver, ISO, and other styles

6

Maia, Mariana Cotta, Mauro Romero Leal Passos, Vandira Maria dos Santos Pinheiro, and Roberto de Souza Salles. "Sexually transmitted diseases in women who aged 50 or older: a retrospective analysis from 2000 to 2017 in a public reference service in Niterói City, Rio de Janeiro State." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p081.

Full text

Abstract:

Introduction: Sexually transmitted diseases (STDs) are more common in young people. There are few studies on STDs in the older population, particularly women. Objective: The aim of this study was to evaluate and characterize, with epidemiological variables, the prevalence of STDs in the female population over 50 years old, in a public reference service in Niterói city, Rio de Janeiro State, Brazil. Methods: The study was carried out at the STD Sector of Universidade Federal Fluminense. It was a descriptive retrospective study of quantitative character, carried out with women aged 50 years or older, attended at the aforementioned teaching, research, and extension unit, from 2000 to 2017. Data collection was performed with documentary research from the records of Sexually Transmitted Diseases Sector of Universidade Federal Fluminense. A total of 6,822 records were analyzed, of which 2,363 were of women. Of these, 50 were medical records of women over 50 years old. The variables used were age, education, marital status, use of condom, diagnosis, sexual and behavior characteristics (extramarital relationships and history of homosexuality), skin color, history of STDs, sex education, the number of sexual partners, and family income. Results: There was a higher prevalence of human papillomavirus (HPV) infection in the form of condyloma acuminata in 48% of cases and cervical intraepithelial neoplasia (CIN) I, II, or III in 20%. Syphilis occurred in 14%, genital herpes and trichomoniasis in 6% each, HIV in 4%, and gonorrhea in 2% of cases. Notably, 64% of women had no pathological history of STDs, 6% had a previous diagnosis of syphilis, and 6%, of HPV. The predominant age group was 50–59 (78%), with a higher prevalence in white women (54%). Most patients (66%) reported having one fixed partner, were married (54%), and had no history of extramarital relationships (64%). In addition, 64% of patients had no degree of sex education and 56% lived on less than two minimum wages. Most patients (78%) reported not using condoms. In 50% of cases, the level of education was incomplete primary education and only 8% had concluded higher education. Conclusion: STDs were more frequent in white women who did not use condoms. The most prevalent STD was HPV infection, as condyloma acuminata in pardo women. HPV infection as a cervical intraepithelial neoplasia (CIN) was the second most common STD in white and pardo women.

APA, Harvard, Vancouver, ISO, and other styles

7

Wang, Weiyi, and Mahendra Piraveenan. "SeCoNet: A Heterosexual Contact Network Growth Model for Human Papillomavirus Disease Simulation." In ASONAM '23: International Conference on Advances in Social Networks Analysis and Mining. New York, NY, USA: ACM, 2023. http://dx.doi.org/10.1145/3625007.3627478.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sawhney, Ramit, and Roopal Jain. "Modified Binary Dragonfly Algorithm for Feature Selection in Human Papillomavirus-Mediated Disease Treatment." In 2018 International Conference on Communication, Computing and Internet of Things (IC3IoT). IEEE, 2018. http://dx.doi.org/10.1109/ic3iot.2018.8668174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Herman, B. "APPLICATIONS OF LASER OPTICAL MICROSCOPIC TECHNIQUES IN DECIPHERING DISEASE SPECIFIC MECHANISMS AND DIAGNOSIS." In Biomedical Optical Spectroscopy and Diagnostics. Washington, D.C.: Optica Publishing Group, 2006. http://dx.doi.org/10.1364/bosd.1996.ft5.

Full text

Abstract:

Accumulating evidence strongly associates human papillomavirus infection with the development of cervical cancers. However, it has also become increasingly clear that HPV infections of the cervix span a wide clinical spectrum from benign lesions to precancerous lesions, with only a minority of infections resulting in invasive cancers, although the reasons for this are not clear. Longitudinal epidemiologic studies using cytologic methods to detect HPV infection have shown that the majority of women infected with HPV will regress spontaneously. In addition, age-stratified data for rates of HPV positivity from cross-sectional studies also suggest that many women clear the infection spontaneously. These results support the concept that many women may be only transiently infected with HPV during their life span and only in women with persistent HPV infection does cervical cancer progress. In addition to persistence of HPV infection, recent epidemiological studies indicate that the amount of high-risk HPV (viral load or HPV gene copy number) in cervicovaginal epithelial cells may be a risk factor for cervical cancer. Thus, a technique which could detect, genotype and quantitate HPV in smears of cervicovaginal epithelial cells would be of major import in assessment of patient clinical status as well as in epidemiological studies relating HPV infection to cervical cancer.

APA, Harvard, Vancouver, ISO, and other styles

10

Wang, Wei, Ellery Gronski, and Paul Lambert. "Abstract 1587: Stress keratin 17 overexpression downregulates CD8+ T cell infiltration in papillomavirus-associated disease." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-1587.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Papillomavirus diseases"

1

Li, Yanhui. Efficacy of non-invasive photodynamic therapy for female lower reproductive tract diseases associated with HPV infection: a comprehensive meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0092.

Full text

Abstract:

Review question / Objective: The critical point of this study was to comprehensively evaluate the curative effect of Photodynamic therapy (PDT) in diseases of female lower reproductive tract associated with the human papillomavirus (HPV) infection. Condition being studied: Traditional clinical recommendations for treating diseases of the female lower reproductive tract include topical therapy with drugs, surgery, intravaginal radiation, carbon dioxide (CO2) laser, etc. Although medication is easy to administer, it has a high recurrence rate and adverse effects such as burning sensation, pain, and dyspareunia. The other traditional treatment method is usually invasive, repeated operation of vaginal perforation, scar, easy recurrence, fertility decline, and other shortcomings. At present, the treatment strategy for cervical squamous intraepithelial lesion, vaginal squamous intraepithelial lesion, condyloma acuminatum, and vulvar lichen sclerosis are to protect the normal organ structure and function as much as possible, reduce recurrence, prevent disease progression and carcinogenesis, and preserve female reproductive function.

APA, Harvard, Vancouver, ISO, and other styles

2

Gidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, Sydne J. Newberry, Peggy Chen, Kelsey O’Hollaren, Nabeel Qureshi, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), May 2021. http://dx.doi.org/10.23970/ahrqepccer244.

Full text

Abstract:

Objective. To conduct a systematic review of the literature on the safety of vaccines recommended for routine immunization in the United States, updating the 2014 Agency for Healthcare Research and Quality (AHRQ) report on the topic. Data sources. We searched MEDLINE®, Embase®, CINAHL®, Cochrane CENTRAL, Web of Science, and Scopus through November 9, 2020, building on the prior 2014 report; reviewed existing reviews, trial registries, and supplemental material submitted to AHRQ; and consulted with experts. Review methods. This report addressed three Key Questions (KQs) on the safety of vaccines currently in use in the United States and included in the Centers for Disease Control and Prevention’s (CDC) recommended immunization schedules for adults (KQ1), children and adolescents (KQ2), and pregnant women (KQ3). The systematic review was supported by a Technical Expert Panel that identified key adverse events of particular concern. Two reviewers independently screened publications; data were extracted by an experienced subject matter expert. Studies of vaccines that used a comparator and reported the presence or absence of adverse events were eligible. We documented observed rates and assessed the relative risks for key adverse events. We assessed the strength of evidence (SoE) across the existing findings from the prior 2014 report and the new evidence from this update. The systematic review is registered in PROSPERO (CRD42020180089). Results. A large body of evidence is available to evaluate adverse events following vaccination. Of 56,608 reviewed citations, 189 studies met inclusion criteria for this update, adding to data in the prior 2014 report, for a total of 338 included studies reported in 518 publications. Regarding vaccines recommended for adults (KQ1), we found either no new evidence of increased risk for key adverse events with varied SoE or insufficient evidence in this update, including for newer vaccines such as recombinant influenza vaccine, adjuvanted inactivated influenza vaccine, and recombinant adjuvanted zoster vaccine. The prior 2014 report noted a signal for anaphylaxis for hepatitis B vaccines in adults with yeast allergy and for tetanus, diphtheria, and acellular pertussis vaccines. Regarding vaccines recommended for children and adolescents (KQ2), we found either no new evidence of increased risk for key adverse events with varied SoE or insufficient evidence, including for newer vaccines such as 9-valent human papillomavirus vaccine and meningococcal B vaccine. The prior 2014 report noted signals for rare adverse events—such as anaphylaxis, idiopathic thrombocytopenic purpura, and febrile seizures—with some childhood vaccines. Regarding vaccines recommended for pregnant women (KQ3), we found no evidence of increased risk for key adverse events with varied SoE among either pregnant women or their infants following administration of tetanus, diphtheria, and acellular pertussis vaccines during pregnancy. Conclusion. Across this large body of research, we found no new evidence of increased risk since the prior 2014 report for key adverse events following administration of vaccines that are routinely recommended. Signals from the prior report remain unchanged for rare adverse events, which include anaphylaxis in adults and children, and febrile seizures and idiopathic thrombocytopenic purpura in children. There is no evidence of increased risk of adverse events for vaccines currently recommended in pregnant women. There remains insufficient evidence to draw conclusions about some rare potential adverse events.

APA, Harvard, Vancouver, ISO, and other styles

3

CIOMS Guide to Active Vaccine Safety Surveillance. Council for International Organizations of Medical Sciences (CIOMS), 2017. http://dx.doi.org/10.56759/hnuw8440.

Full text

Abstract:

With more vaccine solutions available and opportunities for earlier availability of new vaccine products in resource-limited countries (e.g. vaccines against rotavirus, human papillomavirus or pneumococci) as well as new products that address diseases endemic in those countries only (e.g. malaria, dengue among others), generating reliable data about specific safety concerns is becoming a priority for all countries. The Guide offers a practical step-by-step approach and algorithm to aid immunization professionals and decision-makers in determining the best course of action if additional vaccine safety data is needed. The Guide provides a structured process for evaluating whether significant knowledge gaps exist, whether passive safety surveillance is adequate, and if not, methods for and practical aspects of conducting active vaccine safety surveillance. The Guide also includes an essential vaccine information source list for evaluating the extent of data resources and several case studies for review. This CIOMS publication more than any other in recent history focuses on the special needs of the country level organizations responsible for developing vaccines safety surveillance strategies and implementing new vaccination programmes into resource-limited environments.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!